Annual Report 2006 - Boehringer Ingelheim
Annual Report 2006 - Boehringer Ingelheim
Annual Report 2006 - Boehringer Ingelheim
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
128<br />
3.2 Tangible assets<br />
(in millions of EUR)<br />
Procurement/manufacturing costs<br />
Land and<br />
buildings<br />
Technical<br />
facilities and<br />
machines<br />
Other<br />
facilities/<br />
operating<br />
equipment<br />
Advance<br />
payments/<br />
construction<br />
in progress<br />
Balance as of 1. 1. 2005 2,022 1,982 1,312 270 5,586<br />
Currency conversion difference 96 82 61 15 254<br />
Additions due to first consolidation 3 2 2 0 7<br />
Additions 37 77 140 278 532<br />
Disposals -31 -42 -89 -8 -170<br />
Reclassifications 56 98 49 -203 0<br />
Balance as of 31. 12. 2005 2,183 2,199 1,475 352 6,209<br />
Currency conversion difference -115 -81 -56 -17 -269<br />
Additions due to first consolidation 0 0 0 0 0<br />
Additions 54 70 164 308 596<br />
Disposals -78 -57 -82 -2 -219<br />
Reclassifications 66 107 89 -266 -4<br />
Balance as of 31. 12. <strong>2006</strong> 2,110 2,238 1,590 375 6,313<br />
Accumulated depreciations<br />
Balance as of 1. 1. 2005 933 1,030 911 0 2,874<br />
Currency conversion difference 42 43 40 0 125<br />
Additions due to first consolidation 2 1 2 0 5<br />
Additions 125 163 151 0 439<br />
Write-ups 0 -2 0 0 -2<br />
Disposals -13 -37 -82 0 -132<br />
Reclassifications 0 0 0 0 0<br />
Balance as of 31. 12. 2005 1,089 1,198 1,022 0 3,309<br />
Currency conversion difference -58 -45 -38 0 -141<br />
Additions due to first consolidation 0 0 0 0 0<br />
Additions 83 172 164 0 419<br />
Write-ups -1 -1 -1 0 -3<br />
Disposals -36 -48 -73 0 -157<br />
Reclassifications -1 1 0 0 0<br />
Balance as of 31. 12. <strong>2006</strong> 1,076 1,277 1,074 0 3,427<br />
Book value as of 31. 12. 2005 1,094 1,001 453 352 2,900<br />
Book value as of 31. 12. <strong>2006</strong> 1,034 961 516 375 2,886<br />
<strong>Boehringer</strong> <strong>Ingelheim</strong> a n n u a l r e p o r t 2 0 0 6<br />
Total